US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Genomics & Precision Medicine ETF

35.17

+0.08980.26%

Volume:449

Turnover:15.81K

Market Cap:1.93M

PE:- -

High:35.18

Open:35.18

Low:35.17

Close:35.08

52wk High:36.54

52wk Low:23.88

Shares:55.00K

Float Shares:55.00K

Volume Ratio:0.17

T/O Rate:0.82%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Devyser Signs First Illumina-Linked Reagent Rental Deal with Italian Lab

Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1

Guardant Health Director Ian T. Clark Disposes of Common Shares Worth $2.25 Million

Tenaya Therapeutics Q2 Net Loss Widens on Impairment Charge

Tenaya Net Loss Widens to $43.39 Million in Q2 FY26; R&D Expenses Slip to $16.6 Million

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB)

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-05

Thermo Fisher Scientific Inc : Stifel Raises Target Price to $650 from $600

THOMSON REUTERS

LivaNova Q2 FY26 GAAP Diluted EPS Rises to $1.93; Revenue Increases 10.8% Year over Year to $390.6 Million

UK's LivaNova Q2 Revenue Beats Estimates; Lifts 2026 Outlook

LivaNova: Deal Expected to Support Increased Oxygenator Output over Time, Strengthening Co Ability to Satisfy Unmet Customer Demand

THOMSON REUTERS

LivaNova - Enters Long-Term Agreement with Thermo Fisher Scientific for Oxygenator Component Supply

THOMSON REUTERS

LivaNova Plc: Announce Agreement with Thermo Fisher Scientific

THOMSON REUTERS

Wall Street Analysts Are Bullish on Top Healthcare Picks

Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says

MT Newswires Live

Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Fresenius Medical Care (FMS) and Vertex Pharmaceuticals (VRTX)

Alnylam Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $455 from $485

THOMSON REUTERS

Vertex Analysts Lower Their Forecasts Following Q2 Results

Benzinga Earnings

Guardant Health is Maintained at Overweight by Morgan Stanley

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/GNMX/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GNMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","market":"US","secType":"STK","nameCN":"Corgi Genomics & Precision Medicine ETF","latestPrice":35.17,"timestamp":1788292800000,"preClose":35.0802,"halted":0,"volume":449,"delay":0,"changeRate":0.002559848575549851,"floatShares":55000,"shares":55000,"eps":0,"marketStatus":"Pre-Mkt","change":0.0898,"latestTime":"09-02 06:20:16 EDT","open":35.18,"high":35.18,"low":35.17,"amount":15808,"amplitude":0.000285,"askPrice":55.92,"askSize":100,"bidPrice":14.14,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788355800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1302235200000,"exchange":"CBOE","adjPreClose":35.17,"nav":35.06,"aum":1928300,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.17,"preClose":35.17,"latestTime":"16:10 EDT","volume":6,"amount":211.02,"timestamp":1788293404274,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.168796988039177,"impliedVol":0.3582,"impliedVolPercentile":0.4658},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","floatShares":55000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.168796988039177,"shares":55000,"dividePrice":0,"high":35.18,"amplitude":0.000285,"preClose":35.0802,"low":35.17,"week52Low":23.88,"pbRate":"--","week52High":36.5366,"institutionHeld":0,"latestPrice":35.17,"eps":0,"divideRate":0,"volume":449,"delay":0,"ttmEps":0,"open":35.18,"prevYearClose":25.56,"prevWeekClose":35.1817,"prevMonthClose":35.0802,"prevQuarterClose":31.0879,"fiveDayClose":36.5366,"twentyDayClose":30.5513,"sixtyDayClose":27.308},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNMX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNMX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNMX\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657502966","title":"Devyser Signs First Illumina-Linked Reagent Rental Deal with Italian Lab","url":"https://stock-news.laohu8.com/highlight/detail?id=2657502966","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657502966?lang=en_us&edition=fundamental","pubTime":"2026-08-06 14:08","pubTimestamp":1785996506,"startTime":"0","endTime":"0","summary":"Devyser signs first Illumina-linked reagent rental deal with Italian labDevyser signed its first commercial reagent-rental agreement under its Systems Integrator collaboration with Illumina, with a la","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL45p1d5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","ILMN","BK4548","GNOM","BK4534","BK4535","BK4121","BK4585","GNMX","LU0029874061.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657572786","title":"Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2657572786","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657572786?lang=en_us&edition=fundamental","pubTime":"2026-08-06 07:25","pubTimestamp":1785972320,"startTime":"0","endTime":"0","summary":"The latest update is out from Takeda Pharmaceutical Co ( ($JP:4502) ). Takeda has secured U.S. FDA approval for ORZEYFUL, an oral orexin receptor 2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-first-in-class-u-s-approval-for-orexin-therapy-in-narcolepsy-type-1?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-first-in-class-u-s-approval-for-orexin-therapy-in-narcolepsy-type-1?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","MRNY","IBB","IYH","BK4585","TECB","PINK","IDNA","SYNB","RSPH","TBXU","GDOC","MEDI","LABU","BK4588","PSCH","BMED","GNMX","LFSC","XLVX","FRTY","BBP","IEIH","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657726576","title":"Guardant Health Director Ian T. Clark Disposes of Common Shares Worth $2.25 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657726576","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657726576?lang=en_us&edition=fundamental","pubTime":"2026-08-06 05:11","pubTimestamp":1785964302,"startTime":"0","endTime":"0","summary":"Guardant Health director Ian T. Clark disposes of common shares worth $2.25 millionGuardant Health director Ian T. Clark reported option exercises on Aug. 4, 2026, acquiring 9,088 common shares at USD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL7mNXxZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Ian T. Clark Disposes of Common Shares Worth $2.25 Million","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","GNOM","PTH","FFOX","HELX","BK4196","BK4588","LU0109394709.USD","GDOC","GH","GNMX","LFSC","BK4585","LU0889565916.HKD","BK4535","EKG","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657575666","title":"Tenaya Therapeutics Q2 Net Loss Widens on Impairment Charge","url":"https://stock-news.laohu8.com/highlight/detail?id=2657575666","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657575666?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:46","pubTimestamp":1785962781,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics Q2 net loss widens on impairment chargeOverviewUS heart disease therapy developer's Q2 net loss widened, driven by impairment chargeCompany received $10 mln upfront payment from Al","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421DL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","TRDA","PBE","LU0882574055.USD","IMRX","LU0114720955.EUR","LU0889565916.HKD","KYMR","BK4139","BK4563","BK4539","ALNY","BK4585","GNMX","LU0320765992.SGD","LU0109394709.USD","TNYA","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657755525","title":"Tenaya Net Loss Widens to $43.39 Million in Q2 FY26; R&D Expenses Slip to $16.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657755525","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657755525?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:44","pubTimestamp":1785962666,"startTime":"0","endTime":"0","summary":"Tenaya net loss widens to $43.39 million in Q2 FY26; R&D expenses slip to $16.6 millionTenaya Therapeutics posted a Q2 net loss of USD 43.4 million, or USD 0.20 a share, widening from USD 23.3 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL8RShts:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","BK4548","BCDF","LU0114720955.EUR","LU0320765992.SGD","BK4539","LU0109394709.USD","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014039.USD","BK4585","LU2210149790.SGD","BK4139","IE00BN0W2V16.EUR","BK4112","BK4588","PBE","IE00B64PRP62.GBP","SG9999014013.SGD","GNMX","ALNY","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU0882574055.USD","LU2095319765.USD","NDAQ","SG9999014005.SGD","LU0889565916.HKD","TNYA","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657524750","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657524750","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657524750?lang=en_us&edition=fundamental","pubTime":"2026-08-06 02:30","pubTimestamp":1785954614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB) wit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-and-q32-bio-qttb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-and-q32-bio-qttb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362541513.USD","XBI","LU1815336091.USD","SG9999001176.SGD","LU0256863811.USD","BK4023","LU2468319806.SGD","LABU","LU0889565916.HKD","BIB","LU0417517546.SGD","BK4588","BK4532","SG9999001176.USD","GNMX","LU0029874061.USD","LU1093756168.USD","LU0289739699.SGD","IE00B19Z9P08.USD","LU1093756325.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","XLV","LU1585245621.USD","IE00BJT1NW94.SGD","LU0823416689.USD","IBB","LU0061475181.USD","VRTX","PBE","BBH","IBBQ","IE00B2B36J28.USD","LU2089984988.USD","TBXU","LU2417539215.USD","LU2362541273.HKD","IE00B19Z3B42.SGD","LU0079474960.USD","LU1069344957.HKD","LU1430594728.SGD","IE00B19Z9Z06.USD","IE00B19Z3581.USD","BK4581","IDNA","VERX","LU2462157665.USD","QTTB","HCSG","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657369525","title":"NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-05","url":"https://stock-news.laohu8.com/highlight/detail?id=2657369525","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657369525?lang=en_us&edition=fundamental","pubTime":"2026-08-05 23:01","pubTimestamp":1785942065,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-08-05Nasdaq 100.NDXTop PerformersPercent ChangeShopify Inc.SHOP.OQ+17.7%Booking Holdings Inc.BKNG.OQ+6.7%Amgen IncAMGN.OQ+5.7%Alnylam Pharmaceuticals, Inc.ALNY.OQ+4.8%Marriott International, Inc.MAR.OQ+4.3%Bottom PerformersPercent ChangeAstera Labs, Inc.ALAB.OQ-10.3%Space Exploration Technologies CorpSPCX.OQ-7.9%Advanced Micro Devices, Inc.AMD.OQ-7.2%Microchip Technology IncMCHP.OQ-4.0%Dexcom IncDXCM.OQ-4.0%The Nasdaq 100.NDXgained 14.23 points, or 0.05%, to 29,747.39 and recorded 6 new highs and no new lows. 45 stocks rose and 58 fell as declining issues outnumbered advancers by about a 1.3-to-1 ratio.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N4422K4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DAMD","BKNG","LU1267930813.SGD","LU2417539215.USD","SGXZ99366536.SGD","LU1989772923.USD","AMDW","LU2211815571.USD","LU2462591350.SGD","LU2095319765.USD","IE00BJJMRZ35.SGD","IE00BMPRXN33.USD","SPCU","LU0690374615.EUR","CNAV","XNTK","LU2471134796.USD","BK4532","LU0994945656.USD","IE00BQXX3F31.USD","LU1718418525.SGD","LU0390134368.USD","LU1023059063.AUD","LU1316542783.SGD","LU1861215975.USD","LU2237957811.SGD","AMYY","BK4604","LU2264538146.SGD","BK4512","MARS","LU1852331112.SGD","MCHP","LU2242646821.SGD","AIS","SGXZ23171101.USD","AMDY","QQQM","LU1235294995.USD","LU1923622614.USD","07261","LU1064131342.USD","LU1951198990.SGD","LU2054465674.USD","LU2931357623.SGD","GNMX","02834","IE00B95QR487.USD","LU0203345920.USD","IE00BMPRXR70.SGD","GB00B4QBRK32.GBP","LU1691799644.USD","03086","BK4524","NDX","LU2210150020.SGD","LU2357305700.SGD","BK4575","TTEQ","09834","SPCH","NOCT","BK4566","IE00BKVL7J92.USD","NJAN","LU0122379950.USD","PJP","LU2125909247.SGD","LU1989764748.USD","LU0251132253.USD","BK4588","WUGI","TEK","IE00BJT1NW94.SGD","LU0823434583.USD","LU1983299246.USD","SPCM","BK4614","LU0690374961.EUR","AMDG","HXC","LU1720051017.SGD","LU0081259029.USD","IE0001KFT4U8.USD","PBE","LU1720051108.HKD","LU2468319806.SGD","GB00BDT5M118.USD","QLD","SPCG","BKNU","LU0823411888.USD","LU0889566641.SGD","AMUU","LU0345774631.USD","GB00B4LPDJ14.GBP","LU0889565833.HKD","BK4605","LU0077335932.USD","LU2112291526.USD","ALAB","LU1988902786.USD","LU2237957902.USD","BK4504","LU0203347892.USD","IE00B45NX917.SGD","XSD","LU0266013472.USD","LU0786609619.USD","LU2087625088.SGD","SOXY","IE00BSNM7G36.USD","COWG","07522","LU0056508442.USD","LU2860962120.EUR","LU1043141123.HKD","CHPS","LU0082616367.USD","IE00BFTCPJ56.SGD","BIB","IE0002141913.USD","LU0316494557.USD","LU0320765992.SGD","IE00BQXX3D17.EUR","LU1242518931.SGD","LU2125909593.SGD","LU1121112475.USD","LU0058720904.USD","BBH","IE00B1G9WX41.USD","LU0823421333.USD","LU0048584097.USD","IE00BD0PCF45.HKD","TQQQ","WNDR","LU1323610961.USD","LU2360107168.USD","LU2896262040.SGD","EKG","LU0127658192.USD","BK4089","BK4141","LU0274383776.USD","LU2750360997.AUD","CHAT","IE00BZ1G4Q59.USD","QID","SPRX",".IXIC","QQQX","BK4599","NJUL","04332","BK4612","IE00BQXX3C00.GBP","LU2750360641.GBP","LU2456880835.USD","AMDS","LU2404859667.USD","LU2250418816.HKD","LU1633808545.USD","FAI","BK4142","BK4573","LU2247934214.USD","QMAR","QQQ","IE00B0T0GQ85.USD","BK4082","SPAX","LU2236285917.USD","LU0109392836.USD","AMDU","LU2098885051.SGD","LU0426412945.USD","LU2471134523.USD","SHOP","LU1880398471.USD","LU1429558221.USD","LU2108987350.USD","LEGR","LU0353189763.USD","BK4561","LU1548497426.USD","LU2355687059.USD","IE00B5TLWC47.USD","LU0342679015.USD","ORBX","LU1623119135.USD","LU0889565916.HKD","LU1803068979.SGD","LU0109394709.USD","SGXZ51526630.SGD","LU2290526834.HKD","IE00BMPRXQ63.HKD","LU0174119429.USD","IBB","LU2265009873.SGD","LU1242518857.USD","LU2097829019.USD","GAMR","SHPU","LU1951200564.SGD","SMH","MAR","LU2471134879.HKD","LU0823421416.USD","BK4543","BK4533","SG9999001424.SGD","03455","AWAY","BK4139","LU0353189680.USD","IE00B2B36J28.USD","AIQ","LU2326559502.SGD","BK4554","LU0868494617.USD","LU1435385759.SGD","LU1880398554.USD","LU2089985449.USD","SNK","IE0009355771.USD","LU0708994859.HKD","LU0792757196.USD","LU0310800379.SGD","AMDD","SPCQ","LU1861559042.SGD","SQQQ","LU0642271901.SGD","LU2063271972.USD","USXF","LU2210149790.SGD","BK4581","TRFK","LU0225283273.USD","BK4528","LU2242649171.HKD","SPCF","BK4116","TQQY","LU0979878070.USD","LU1496350171.SGD","ILDR","LU0128525929.USD","FTXL","QDEC","IE00B4R5TH58.HKD","LABX","BAI","SMHX","SPCX","NAPR","LU2360106780.USD","LU2458330243.SGD","LU0354030438.USD","TBXU","LU1267930573.SGD","LU1061106388.HKD","LU1046421795.USD","LU1804176565.USD","IETC","LU0719512351.SGD","LU1571399168.USD","LU1923623000.USD","07266","LU1861220033.SGD","SSPC","09086","LU1983260115.SGD","LU2461242641.AUD","IE0004445239.USD","WARP","LU2361044949.HKD","HEAL","LU0198837287.USD","SHPD","BK4613","DXCM","IE0009356076.USD","LU1303367103.USD","LU1232071149.USD","LU1861558580.USD","IBBQ","LU0133085943.USD","WSPC","LU1712237335.SGD","03034","GPIQ","WISE","AIPI","LU0823434740.USD","ALNY","LU1043141396.HKD","BK4551","LU0868494708.USD","BK4585","LU0348723411.USD","LU0354030511.USD","PSQ","QQQA","IE00B1BXHZ80.USD","IE00B5949003.HKD","LU0289739699.SGD","LU1989764664.SGD","LU0426417589.USD","LU0114720955.EUR","LU0942090050.USD","SG9999001440.SGD","LU0210536198.USD","LU2433249047.HKD","LU2089984988.USD","LU2404859741.USD","AMD","BK4534","LU0029864427.USD","AMGN","LU2471134952.CNY","AMDL","LU2361045086.USD","SGXZ81514606.USD","SPAL","LU0557290698.USD","LOFF","LU1496350502.SGD","SG9999004303.SGD","SOXX","LU1989772840.SGD","PSI","LU0882574055.USD","LU0345774391.USD","07568","LU2361044865.SGD","LU1823568750.SGD","ARTY","LU2242652126.USD","BK4529","LU1699723380.USD","LU1057294990.SGD","BK4548","LU2458330169.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657546226","title":"Thermo Fisher Scientific Inc : Stifel Raises Target Price to $650 from $600","url":"https://stock-news.laohu8.com/highlight/detail?id=2657546226","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657546226?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:16","pubTimestamp":1785928593,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN4421HD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1791710582.SGD","GB00BDT5M118.USD","LU1153585028.USD","LU2125910179.SGD","BK4121","LU0957791311.USD","GNMX","LU1064131342.USD","LU1280957306.USD","LU2720916845.USD","LU2764263039.SGD","LU2764263203.CNY","IE00B19Z8W00.USD","IE00BQXX3D17.EUR","LU0266013472.USD","LU0122379950.USD","LU1670627923.USD","IE0009355771.USD","LU0345770993.USD","HRTS","LU2543165471.USD","LU0342679015.USD","LU1623119135.USD","LU0061474960.USD","LU1854103824.USD","LU0557290698.USD","LU0640476718.USD","LU1989771016.USD","TMO","LU1791710400.SGD","FMED","LU1923621640.USD","LU1923622291.USD","LU0316494557.USD","LU2211815571.USD","TMED","LU1854104046.USD","LU0345770308.USD","LU2089984988.USD","LU0823416689.USD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0528227936.USD","LU2764262908.HKD","IE0034235188.USD","LU0114720955.EUR","LU1023059063.AUD","LU2125909916.SGD","LU2041044095.USD","LU1720051017.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657548533","title":"LivaNova Q2 FY26 GAAP Diluted EPS Rises to $1.93; Revenue Increases 10.8% Year over Year to $390.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657548533","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657548533?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:13","pubTimestamp":1785924796,"startTime":"0","endTime":"0","summary":"LivaNova Q2 FY26 GAAP diluted EPS rises to $1.93; revenue increases 10.8% year over year to $390.6 millionLivaNova posted Q2 revenue of $390.6 million, up 10.8% from a year earlier; U.S. GAAP diluted ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDLyk5Bh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","LU1854103824.USD","LU1720051017.SGD","LU0882574055.USD","BK4534","LU2357305700.SGD","LIVN","LU0011850046.USD","GNMX","IE0034235188.USD","IE00B19Z9505.USD","BK4535","LU2089984988.USD","LU2092937221.SGD","LU0122379950.USD","LU0528227936.USD","LU2125909593.SGD","TMO","LU2112291526.USD","LU2764263203.CNY","LU1923622291.USD","IE0002141913.USD","LU1153585028.USD","LU1815333072.USD","LU2065169927.USD","LU1623119135.USD","IE00BQXX3C00.GBP","TMED","LU0114720955.EUR","LU0061474960.USD","IE00BKPKM429.USD","LU0208291251.USD","LU0640476718.USD","LFSC","LU2125909247.SGD","LU2211815571.USD","LU0234572021.USD","LU2298321311.HKD","HRTS","LU2764262908.HKD","GB00BDT5M118.USD","LU0316494557.USD","LU0957791311.USD","LU1670628061.USD","LU1988902786.USD","LU2764263039.SGD","LU1989771016.USD","IE00BJJMRZ35.SGD","FMED","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657654837","title":"UK's LivaNova Q2 Revenue Beats Estimates; Lifts 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657654837","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657654837?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:11","pubTimestamp":1785924675,"startTime":"0","endTime":"0","summary":"UK's LivaNova Q2 revenue beats estimates; lifts 2026 outlookOverviewUK medical technology firm's Q2 revenue grew 10.8%, beating analyst expectationsAdjusted EPS for Q2 beat analyst expectationsCompany","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4420EB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","GNMX","BK4581","LU2211815571.USD","MADE","BK4082","LU0345770993.USD","LU2463526074.USD","LU0528227936.USD","IE00BQXX3F31.USD","IE000M9KFDE8.USD","TMED","IE0002141913.USD","LIVN","LU0320765489.SGD","BK4585","LU0096362180.USD","HRTS","LU2720916845.USD","IE0034235188.USD","LU1815333072.USD","LU1064131342.USD","LU1815336091.USD","LU1791710400.SGD","LU1169589451.USD","LU0057025933.USD","LU0203347892.USD","ITGR","LU2360108059.USD","LU0342679015.USD","TMO","LU2041044095.USD","CLPT","IE00BKPKM429.USD","LFSC","LU1803068623.USD","LU0061474960.USD","IE00B19Z8X17.USD","LU0114720955.EUR","LU2125909916.SGD","IE00B4R5TH58.HKD","LU0566484027.USD","CMI","FMED","LU0266013472.USD","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU1559883803.SGD","LU2468319806.SGD","LU0124676726.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657881548","title":"LivaNova: Deal Expected to Support Increased Oxygenator Output over Time, Strengthening Co Ability to Satisfy Unmet Customer Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2657881548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657881548?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2125909759.SGD","LU2211815571.USD","LU2264538146.SGD","LU0342679015.USD","LU1983299246.USD","LIVN","LU0011850046.USD","LU1670628061.USD","LU2360108059.USD","LU1153585028.USD","LU2764262908.HKD","GNMX","LU0208291251.USD","LFSC","LU1923621640.USD","BK4533","IE0002141913.USD","LU2298321311.HKD","FMED","TMED","LU0114720955.EUR","LU1064131342.USD","LU1548497426.USD","LU1803068623.USD","LU0316494557.USD","LU0557290698.USD","LU0528227936.USD","IE00B19Z8X17.USD","IE00B1BXHZ80.USD","LU0070302665.USD","LU2065169927.USD","IE00B19Z8W00.USD","LU2468319806.SGD","LU0432979614.USD","LU1988902786.USD","LU0345770308.USD","TMO","LU0096362180.USD","LU1023059063.AUD","LU1633808545.USD","LU2357305700.SGD","LU2125910336.SGD","BK4581","LU1712237335.SGD","LU2089984988.USD","LU1791710582.SGD","LU2211814178.USD","IE00B19Z9505.USD","LU1291159041.SGD","HRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510022","title":"LivaNova - Enters Long-Term Agreement with Thermo Fisher Scientific for Oxygenator Component Supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510022?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1153585028.USD","LU1023059063.AUD","LU1720051108.HKD","LU2543165471.USD","LU1720051017.SGD","LFSC","LU1803068623.USD","LU1923622614.USD","LU0011850046.USD","LU2065170008.USD","LU2089984988.USD","LU2360108059.USD","TMO","LU2264538146.SGD","LU2063271972.USD","IE00B2B36J28.USD","LU1712237335.SGD","LU2433249047.HKD","LU0061474960.USD","BK4533","IE00B1BXHZ80.USD","IE00BJJMRZ35.SGD","LU0882574055.USD","LU1633808545.USD","LU2125909916.SGD","LU2764263039.SGD","LU0528227936.USD","BK4585","LU1623119135.USD","IE0034235188.USD","LU2468319806.SGD","LU1291159041.SGD","LU0345770993.USD","GNMX","LU2764262908.HKD","LU0823416689.USD","BK4082","IE00BFTCPJ56.SGD","HRTS","LU1983299246.USD","IE00BQXX3D17.EUR","LU1989771016.USD","TMED","LU1057294990.SGD","LIVN","FMED","LU1854104046.USD","LU1854103824.USD","LU1064131342.USD","LU1988902786.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657013510","title":"LivaNova Plc: Announce Agreement with Thermo Fisher Scientific","url":"https://stock-news.laohu8.com/highlight/detail?id=2657013510","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657013510?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LFSC","LU2065169927.USD","LU1815333072.USD","IE00BJJMRZ35.SGD","LU2092937221.SGD","LU2112291526.USD","GNMX","LU0114720955.EUR","LU0316494557.USD","LU2764262908.HKD","IE0034235188.USD","IE00BQXX3C00.GBP","LU1623119135.USD","IE0002141913.USD","LU1670628061.USD","TMO","LU0882574055.USD","LU0070302665.USD","LU0640476718.USD","LU2125909593.SGD","FMED","LU0234572021.USD","LU2298321311.HKD","LU0957791311.USD","GB00BDT5M118.USD","LU1989771016.USD","LU1720051017.SGD","BK4535","IE00B4R5TH58.HKD","HRTS","IE00BKPKM429.USD","LU1923622291.USD","LU1153585028.USD","LU1988902786.USD","BK4534","IE00B19Z9505.USD","LU0061474960.USD","LU0528227936.USD","LU1854103824.USD","TMED","LU2764263039.SGD","LU0122379950.USD","LU2357305700.SGD","LU2089984988.USD","LU2211815571.USD","LU2764263203.CNY","LIVN","LU0208291251.USD","LU0011850046.USD","LU2125909247.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657659121","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657659121","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657659121?lang=en_us&edition=fundamental","pubTime":"2026-08-05 11:00","pubTimestamp":1785898840,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Illumina (ILMN) and Travere Therapeutics (TVTX) with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-276?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-276?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4548","BK4588","BK4139","LFSC","TVTX","GNOM","ILMN","GNMX","LU0029874061.USD","BK4534","BK4535","BK4121","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657568150","title":"Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2657568150","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657568150?lang=en_us&edition=fundamental","pubTime":"2026-08-05 01:05","pubTimestamp":1785863115,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals  remains well positioned heading into the second half of 2026 as several pipeline catalysts approach, while upcoming competitor cystic fibrosis data is unlikely to materially affect its outlook, UBS Securities said in a note Tuesday.The investment firm said expectations around the competitive threat have already moderated, noting Vertex's once-daily Alyftrek has shown strong efficacy and that the rival study's narrower patient population may limit its read-through to Vertex.UBS said it remains most optimistic about phase III data for inaxaplin in APOL1-mediated kidney disease expected in early 2027, saying positive results could position Vertex as the first company to market in the indication and further expand its nephrology franchise.It also highlighted Phase II data expected this fall in APOL1-mediated kidney disease patients with Type 2 diabetes or moderate proteinuria, a population that could expand the drug's addressable market by 50% to 100%.UBS has a buy ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","LU0432979614.USD","LU1778281490.HKD","LU1674673428.USD","LU2362541513.USD","IE00B19Z9Z06.USD","SGXZ57979304.SGD","IDNA","LU2456880835.USD","LU0823416689.USD","BK4533","LU2362540622.SGD","BK4588","LU2324357040.USD","IBB","BK4139","IE00BJJMRZ35.SGD","LU1430594728.SGD","IE00B19Z3B42.SGD","IE00B2B36J28.USD","BK4585","BK4567","LU0234570918.USD","LU0256863811.USD","LU0566484027.USD","BIB","BK4532","LU1674673691.USD","IE0002270589.USD","LU1035775433.USD","TBXU","LU1093756168.USD","LU1093756325.SGD","LU2236285917.USD","LU1815336091.USD","IE00BZ9MQY76.HKD","VERX","LU0320765992.SGD","LU1585245621.USD","SG9999001176.SGD","VRTX","LU2237438978.USD","PBE","LU0417517546.SGD","LU2468319806.SGD","IBBQ","GNMX","BBH","IE0009355771.USD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657255048","title":"Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2657255048","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657255048?lang=en_us&edition=fundamental","pubTime":"2026-08-05 00:02","pubTimestamp":1785859337,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals  reported a solid Q2 and raised its outlook, highlighting the strength of its core business and pipeline, RBC Capital Markets said in a note emailed Tuesday.The analysts said the stock could benefit once the Sionna Therapeutics  data overhang clears, with upcoming catalysts including the launch of new products, the expected closing of the Crinetics Pharmaceuticals  deal, and additional pipeline readouts.The stock does not fully reflect the potential upside from pipeline opportunities, including kidney programs, expansion of povetacicept into autoimmune diseases such as IgA nephropathy and generalized myasthenia gravis, and the longer-term potential of suzetrigine in chronic pain, the analysts added.\"We believe that given Vertex's strong core revenue, a pipeline that is increasingly becoming more mature, and with optionality to further diversify pipeline with external [business development,] shares should command a higher valuation,\" the analysts said.RBC lowered ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SGXZ57979304.SGD","LU1815336091.USD","IE00B2B36J28.USD","BK4139","IBB","IE00B19Z3B42.SGD","BK4585","LU0823416689.USD","LU0566484027.USD","SION","IBBQ","LU0234570918.USD","BK4567","LU0320765992.SGD","LU1430594728.SGD","BIB","BBH","VERX","LU2324357040.USD","IE0002270589.USD","IE00B19Z9Z06.USD","LU1093756325.SGD","VRTX","CRNX","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00BZ9MQY76.HKD","BK4532","LU0417517546.SGD","LU2362540622.SGD","GNMX","LU1674673691.USD","TBXU","IDNA","LU0256863811.USD","LU0889565916.HKD","LU2236285917.USD","LU2468319806.SGD","LU1035775433.USD","LU1778281490.HKD","BK4533","BK4588","LU0432979614.USD","LU2362541513.USD","LU1585245621.USD","LU1674673428.USD","PBE","LU2237438978.USD","LU2456880835.USD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656571065","title":"Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Fresenius Medical Care (FMS) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656571065","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656571065?lang=en_us&edition=fundamental","pubTime":"2026-08-04 23:00","pubTimestamp":1785855621,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on AMN Healthcare Services (AMN), Fresenius Medical Care (FMS) and V...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amn-healthcare-services-amn-fresenius-medical-care-fms-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amn-healthcare-services-amn-fresenius-medical-care-fms-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VRTX","BIB","LU1093756325.SGD","BK4533","IE00B4R5TH58.HKD","BK4581","LABU","SG9999001176.USD","LU2089984988.USD","FMS","IDNA","GNMX","BK4585","IE00B2B36J28.USD","AMN","IE00BJT1NW94.SGD","IE0002141913.USD","VERX","LU2362541273.HKD","IBB","LU2362540622.SGD","BK4139","LU0109394709.USD","IE00B19Z3581.USD","IE0009355771.USD","LU0320765992.SGD","LU2324357040.USD","LU1559883803.SGD","TBXU","IE00BFTCPJ56.SGD","IE00BZ9MQY76.HKD","LU1035775433.USD","IE00B19Z9P08.USD","LU2456880835.USD","BBH","IE00B894F039.SGD","IE00B19Z9Z06.USD","LU2236285917.USD","PBE","LU1815336091.USD","LU1674673691.USD","LU1430594728.SGD","IBBQ","LU2362541513.USD","LU0757428866.USD","XLV","LU1674673428.USD","XBI","LU1069344957.HKD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656540305","title":"Alnylam Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $455 from $485","url":"https://stock-news.laohu8.com/highlight/detail?id=2656540305","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656540305?lang=en_us&edition=fundamental","pubTime":"2026-08-04 22:18","pubTimestamp":1785853138,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nAZN4TBOJ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALNY","BK4548","BK4585","LU0882574055.USD","LU0889565916.HKD","BK4139","LU0114720955.EUR","BK4588","LU0320765992.SGD","PBE","GNMX","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656590955","title":"Vertex Analysts Lower Their Forecasts Following Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2656590955","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656590955?lang=en_us&edition=fundamental","pubTime":"2026-08-04 21:15","pubTimestamp":1785849333,"startTime":"0","endTime":"0","summary":"Vertex Inc (NASDAQ:VERX) reported strong Q2 earnings, exceeding analyst estimates. Sales for Q3 also expected to beat market estimates.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/08/60906332/vertex-analysts-lower-their-forecasts-following-q2-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","LU2237438978.USD","LU2456880835.USD","VRTX","IBB","LU1674673428.USD","BIB","LU0234570918.USD","LU1815336091.USD","VERX","IE00B19Z9Z06.USD","LU0109394709.USD","IE00B19Z3581.USD","LU1430594728.SGD","IE00B19Z9P08.USD","BK4533","SGXZ57979304.SGD","IE0009355771.USD","LU0289739699.SGD","BBH","LU0757428866.USD","IBBQ","BK4585","LU2468319806.SGD","GNMX","SG9999001176.SGD","LU0079474960.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU2324357040.USD","SG9999001176.USD","LU0889565916.HKD","LU1093756168.USD","LU1559883803.SGD","PBE","IDNA","TBXU","LU2236285917.USD","IE00B894F039.SGD","IE00BJT1NW94.SGD","LU1674673691.USD","LU0256863811.USD","BK4567","BK4139","LU2362541273.HKD","LU2362541513.USD","LU0566484027.USD","LU0432979614.USD","BK4588","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656556059","title":"Guardant Health is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2656556059","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656556059?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:44","pubTimestamp":1785847440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0320765992.SGD","FFOX","LU0109394709.USD","GDOC","LFSC","BK4551","BK4588","GNOM","HELX","BK4196","PTH","GNMX","BK4535","GH","EKG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}